Type 1 diabetes usually begins in children and young adults, but it can happen at any age. For those who are undiagnosed, the ...

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every ...

The immunotherpay can give children and adults three extra years before they need to use insulin.

A landmark UK study involving tens of thousands of families has shown that childhood screening for type 1 diabetes is effective, laying the groundwork for a UK-wide childhood screening program.

A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.

It has been dubbed the biggest diabetes breakthrough for a century.

Type 1 diabetes researcher Anette Ziegler has never believed the word impossible. Important steps in her career have been driven by a spirit of opening new paths and constantly pushing beyond ...

A UK study has shown that routine childhood screening for type 1 diabetes (T1D) is feasible and could prevent thousands of children being diagnosed during a medical emergency. The first phase of the ...

Sanofi Diabetes, a division of Sanofi-Aventis, has launched a new mobile game for iOS and Android phones in the United Kingdom. The game, called Mission T1D, is meant to be educational, to teach ...

As the third heatwave of the year continues, and millions are expected to jet off abroad this summer, health experts have ...